Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Dec 7;11(12):2250-2255.
doi: 10.2215/CJN.02590316. Epub 2016 Sep 22.

Anxiety in Patients Treated with Hemodialysis

Affiliations
Review

Anxiety in Patients Treated with Hemodialysis

Scott D Cohen et al. Clin J Am Soc Nephrol. .

Abstract

Anxiety is a common yet frequently overlooked psychiatric symptom in patients with ESRD treated with hemodialysis (HD). Anxiety is characterized by disruptive feelings of uncertainty, dread, and fearfulness. A variety of common medical complaints may be manifestations of an anxiety disorder, including palpitations, tremors, indigestion, numbness/tingling, nervousness, shortness of breath, diaphoresis, and fear. It is essential for the clinician to rule out specific medical conditions, including cardiovascular, pulmonary, and neurologic diseases, before ascribing these symptoms to an anxiety disorder. In addition, there is considerable overlap between the symptoms of anxiety and those of depression and uremia. This psychiatric condition has a significant adverse impact on patients' perception of quality of life. Little is known regarding the prevalence and impact of anxiety disorders in patients with ESRD treated with HD; however, many of the seemingly irrational behaviors of patients, or behaviors which place them in conflict with staff and physicians, such as behavioral noncompliance, may be the expression of an underlying anxiety disorder. In this review, we present three clinical vignettes, highlighting the impact of anxiety disorders in patients with ESRD treated with HD.

Keywords: Anxiety Disorders; Chronic; Depressive Disorder; Dyspepsia; Dyspnea; Fear; Hemodialysis; Humans; Hypesthesia; Kidney Failure; Prevalence; Tremor; Uncertainty; anxiety; benzodiazepine; depression; quality of life; renal dialysis; uremia.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Schematic depiction of the interaction of psychosocial and environmental factors and anxiety as they affect patient perception of quality of life.

References

    1. Cukor D, Ver Halen N, Fruchter Y: Anxiety and quality of life in ESRD. Semin Dial 26: 265–268, 2013 - PubMed
    1. Cukor D, Coplan J, Brown C, Friedman S, Newville H, Safier M, Spielman LA, Peterson RA, Kimmel PL: Anxiety disorders in adults treated by hemodialysis: a single-center study. Am J Kidney Dis 52: 128–136, 2008 - PubMed
    1. Cukor D, Coplan J, Brown C, Peterson RA, Kimmel PL: Course of depression and anxiety diagnosis in patients treated with hemodialysis: a 16-month follow-up. Clin J Am Soc Nephrol 3: 1752–1758, 2008 - PMC - PubMed
    1. Stein MB, Sareen J: Generalized Anxiety Disorder. N Engl J Med 373: 2059–2068, 2015 - PubMed
    1. American Psychiatric Association: Diagnostic and statistical manual of mental disorders, 5th Ed., Arlington, VA, American Psychiatric Association, 2013